CABOT WEALTH MANAGEMENT INC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
CABOT WEALTH MANAGEMENT INC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$2,245,000
+32.5%
18,301
-5.4%
0.45%
+10.6%
Q1 2020$1,694,000
-18.3%
19,340
-2.4%
0.40%
+1.2%
Q4 2019$2,073,000
-12.6%
19,823
-3.8%
0.40%
-20.2%
Q3 2019$2,371,000
-34.1%
20,615
-1.2%
0.50%
-34.0%
Q2 2019$3,597,000
+37.2%
20,865
+34.2%
0.76%
+31.8%
Q1 2019$2,621,000
+86.0%
15,548
+7.4%
0.58%
+67.4%
Q4 2018$1,409,00014,4700.34%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders